Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMOD2 | CTRPv2 | pan-cancer | AAC | 0.27 | 8e-11 |
mRNA | ZNF428 | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-11 |
mRNA | MRPL24 | CTRPv2 | pan-cancer | AAC | -0.23 | 1e-10 |
mRNA | FBXO25 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
mRNA | RTN1 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-10 |
mRNA | ZNF71 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-10 |
mRNA | ZNF493 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
mRNA | ZNF491 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
mRNA | XKR7 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
mRNA | FXYD6 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-10 |